AU4119397A - Novel combination preparations and their use in immunodiagnosis and immunotherapy - Google Patents

Novel combination preparations and their use in immunodiagnosis and immunotherapy

Info

Publication number
AU4119397A
AU4119397A AU41193/97A AU4119397A AU4119397A AU 4119397 A AU4119397 A AU 4119397A AU 41193/97 A AU41193/97 A AU 41193/97A AU 4119397 A AU4119397 A AU 4119397A AU 4119397 A AU4119397 A AU 4119397A
Authority
AU
Australia
Prior art keywords
immunodiagnosis
immunotherapy
novel combination
combination preparations
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41193/97A
Inventor
Heribert Bohlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIVA DIAGNOSTIKA DIAGNOSTISCHE PRODUKTE GmbH
Original Assignee
VIVA DIAGNOSTIKA DIAGNOSTISCHE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19634730A external-priority patent/DE19634730A1/en
Priority claimed from DE1997103699 external-priority patent/DE19703699A1/en
Application filed by VIVA DIAGNOSTIKA DIAGNOSTISCHE filed Critical VIVA DIAGNOSTIKA DIAGNOSTISCHE
Publication of AU4119397A publication Critical patent/AU4119397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU41193/97A 1996-08-28 1997-08-18 Novel combination preparations and their use in immunodiagnosis and immunotherapy Abandoned AU4119397A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19634730 1996-08-28
DE19634730A DE19634730A1 (en) 1996-08-28 1996-08-28 Bispecific antibodies, useful for imaging, diagnosis and treatment
DE19703699 1997-02-03
DE1997103699 DE19703699A1 (en) 1997-02-03 1997-02-03 Combination preparation for immunological diagnosis and treatment
PCT/EP1997/004493 WO1998008875A1 (en) 1996-08-28 1997-08-18 Novel combination preparations and their use in immunodiagnosis and immunotherapy

Publications (1)

Publication Number Publication Date
AU4119397A true AU4119397A (en) 1998-03-19

Family

ID=26028819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41193/97A Abandoned AU4119397A (en) 1996-08-28 1997-08-18 Novel combination preparations and their use in immunodiagnosis and immunotherapy

Country Status (2)

Country Link
AU (1) AU4119397A (en)
WO (1) WO1998008875A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999066951A2 (en) * 1998-06-22 1999-12-29 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7138103B2 (en) 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7387772B1 (en) 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US6962702B2 (en) 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7833528B2 (en) 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
WO2001032207A1 (en) * 1998-10-30 2001-05-10 United States Army Medical Research And Materiel Command Methods for conferring active/passive immunotherapy
HUE028175T2 (en) 2008-11-07 2016-12-28 Amgen Res (Munich) Gmbh Treatment of acute lymphoblastic leukemia
HUE025452T2 (en) * 2008-11-07 2016-05-30 Amgen Res (Munich) Gmbh Treatment of pediatric acute lymphoblastic leukemia
WO2011003780A1 (en) * 2009-07-06 2011-01-13 F. Hoffmann-La Roche Ag Bi-specific digoxigenin binding antibodies
DE102013105144A1 (en) * 2013-05-17 2014-11-20 Arno Thaller Combination pharmaceutical preparation with an anti-idiotypic antibody fragment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
WO1992020746A1 (en) * 1991-05-14 1992-11-26 Hybritech, Incorporated Polymeric compositions having bound antibodies
US5861156A (en) * 1993-01-08 1999-01-19 Creative Biomolecules Methods of delivering agents to target cells
GB9412166D0 (en) * 1993-09-22 1994-08-10 Medical Res Council Retargetting antibodies
JPH0829419A (en) * 1994-07-12 1996-02-02 Aisin Seiki Co Ltd Antigenic substance detecting method

Also Published As

Publication number Publication date
WO1998008875A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU5752398A (en) Novel ketobenzamides and their use
AU4397297A (en) Antibody against human parathormone related peptides
AU6990796A (en) Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
IL118237A0 (en) Polysiloxane-polyol macromers their preparation and their use
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
AU7177798A (en) Cosmetic preparations
AU3804297A (en) Chair for use in construction
AU5494294A (en) Hop extract and use thereof
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU4266596A (en) Composition and use
SG79212A1 (en) Reactive dyes, their preparation and use
AU7177698A (en) Cosmetic preparations
AU4556797A (en) Substituted phthalocyanines and their use
AU3159499A (en) Antigen preparation and use
AU7401598A (en) Epoxide-amine dendrimers and the preparation and use thereof
AU3902297A (en) Two human nsp-like proteins
AU4119397A (en) Novel combination preparations and their use in immunodiagnosis and immunotherapy
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU4236097A (en) Mhc peptides and methods of use
SG73449A1 (en) Fibre-reactive dyes their preparation and their use
ZA96240B (en) Novel peptides their preparation and use
AU3634595A (en) Bis-oxazolidines and their use
AU3200197A (en) New composition and methods
AU4819897A (en) Films having improved characteristics and methods for their preparation and use
AU5557698A (en) Novel calpaines, their preparation and use